MedTrace Logo

Effects of Yakult Ingestion in Residents and Staffs at Indonesian Elderly Houses

NCT05308745 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2022-04-04

No results posted yet for this study

Summary

A study to investigate the effect of Yakult® containing L. casei Shirota on the intestinal microbiota, intestinal environment, and stool frequency in healthy adult and elderly subjects in Indonesia. The clinical phase of this study was conducted for 26 weeks in three different elderly houses. The subjects were grouped into two categories: probiotic and placebo group, according whether the subjects consumed product or placebo samples. Fecal sampling were taken three times during the study.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Yakult®

Fermented milk drink containing over 6.5×10\^9 CFUs of L. casei Shirota/65 ml

DIETARY_SUPPLEMENT

Placebo

Taste, appearance, component, and number of calories are the same as Yakult®, non-fermented milk product

Sponsors & Collaborators

  • Yakult Honsha Co., LTD

    collaborator INDUSTRY

  • Endang Sutriswati Rahayu

    lead OTHER

Principal Investigators

  • Endang Sutriswati Rahayu · Gadjah Mada University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-04
Primary Completion
2018-10-18
Completion
2022-03-24

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05308745 on ClinicalTrials.gov